Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Fresenius Medical Care AG (FMCQF) over the last 17 years, with Q3 2025 value amounting to -$1.3 billion.

  • Fresenius Medical Care AG's Cash from Financing Activities fell 15330.44% to -$1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 billion, marking a year-over-year increase of 502.53%. This contributed to the annual value of -$2.7 billion for FY2024, which is 3730.01% down from last year.
  • According to the latest figures from Q3 2025, Fresenius Medical Care AG's Cash from Financing Activities is -$1.3 billion, which was down 15330.44% from $89.7 million recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Cash from Financing Activities registered a high of $89.7 million during Q2 2025, and its lowest value of -$1.3 billion during Q3 2025.
  • For the 5-year period, Fresenius Medical Care AG's Cash from Financing Activities averaged around -$477.9 million, with its median value being -$412.3 million (2021).
  • In the last 5 years, Fresenius Medical Care AG's Cash from Financing Activities tumbled by 1465663.66% in 2024 and then soared by 10994.47% in 2025.
  • Fresenius Medical Care AG's Cash from Financing Activities (Quarter) stood at -$409.0 million in 2021, then surged by 70.09% to -$122.3 million in 2022, then plummeted by 555.76% to -$802.3 million in 2023, then fell by 28.56% to -$1.0 billion in 2024, then decreased by 28.68% to -$1.3 billion in 2025.
  • Its Cash from Financing Activities stands at -$1.3 billion for Q3 2025, versus $89.7 million for Q2 2025 and -$146.0 million for Q1 2025.